Table 3.

Details of applied treatments

Author/s	Mean delay from injury to Ilizarov treatment (range) months	Mean previous operative procedures (range)	Etiology n (%)
			Acute trauma	Aseptic lesion	Infected lesion
Madhusudhan et al.	7.8 (nr)	3 (2–5)	0 (0)	0 (0)	22 (100)
Pirwani et al.	nr	nr	0 (0)	0 (0)	16 (100)
Bumbasirevic et al.	8.6 (16–24)	1.3 (1–3)	0 (0)	0 (0)	30 (100)
Megas et al.	7.8 (4–14)	4.8 (3–6)	0 (0)	0 (0)	9 (100)
Lin et al.	nr	nr	0 (0)	0 (0)	16 (100)
Babar et al.	nr	nr	nr	nr	nr
Feng et al.	8.6 (6–24)	6 (3–14)	0 (0)	0 (0)	21 (100)
Krappinger et al.	13 (10–41)	10.1 (2–35)	0 (0)	6 (40)	9 (60)
Selim	nr	nr	10 (100)	0 (0)	0 (0)
Shadid et al.	21 (1–62)	1.08 (1–2)	0 (0)	0 (0)	12 (100)
Spiegl et al.	9.5 (1–22.6)	1 (nr)	0 (0)	0 (0)	25 (100)
Xu et al.	8.8 (6–24)	6 (3–14)	0 (0)	0 (0)	30 (100)
Yin et al.	22.8 (4–10)	2.4 (1–8)	0 (0)	0 (0)	66 (100)
Morsy	18.2 (7–26)	nr	0 (0)	7 (58)	5 (42)
Marais et al.	3 (nr)	nr	0 (0)	0 (0)	7 (100)
Azzam et al.	nr	nr	0 (0)	8 (26.7)	22 (73.3)
Bernstein et al.	nr	nr	0 (0)	14 (47)	16 (53)
Khan et al.	11.9 (1–36)	2 (nr)	0 (0)	0 (0)	24 (100)
Peng et al.	7.1 (1.4–11.6)	6.3 (3–10)	0 (0)	0 (0)	58 (100)
Wani et al.	8.2 (4.6–28)	2.5 (1–5)	0 (0)	0 (0)	26 (100)
Aboumira et al.	nr	nr	0 (0)	7 (28)	18 (72)
Aktuglu et al.	nr	3.64 (0–11)	0 (0)	8 (33.3)	16 (66.6)
Fürmetz et al.	nr	nr	0 (0)	7 (87.5)	1 (12.5)
Rohilla et al.	5.8 (0.9–22.8)	1.22 (nr)	0 (0)	0 (0)	35 (100)
Tetsworth et al.	nr	4.5 (nr)	0 (0)	0 (0)	21 (100)
Yilihamu et al.	nr	nr	0 (0)	0 (0)	14 (100)
Zhang et al.	16.9 (3–45)	4.25 (nr)	0 (0)	0 (0)	16 (100)

nr not reported